Home LiteratureArticle Details
PMID: 4179321 Published · ppublish English Journal Article

Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors.

Bulletin of the World Health Organization ·Vol. 39 ·No. 4 ·1968-00-00 ·Pages 587-606

Beutner EH, Sepulveda MR, Barnett EV

Abstract

Reproducible titres of indirect immunofluorescent (IF) staining with antinuclear factor (ANF)-containing sera could be obtained with different antihuman IgG conjugates by quantitative adjustments of their characteristics. Conversely, one ANF yielded a broad range of ANF titre (80-640) upon appropriate adjustments of the conjugate characteristics. The same and related characteristics of the conjugates also afforded a basis for quantitatively defining the conditions under which non-specific staining (NSS) appeared. The salient characteristics of the anti-IgG conjugates include: (1) their strength of antiglobulin (expressed as units/ml of precipitating antibody or mug antibody N/ml); (2) their apparent fluorescein concentration (in mug F/ml); (3) their protein concentration (in mg/ml). Optical and immunologic sensitivity ratios are calculated from these conjugate characteristics. Optical sensitivity (expressed as fluorescein concentration to protein concentration (F/P) ratios), immunological sensitivities (expressed as units/1% protein) and the dilution employed serve to characterize quantitatively anti-IgG conjugates adequately to define their specific and non-specific staining properties.

MeSH Terms
Antibodies, Antinuclear Fluorescent Antibody Technique Humans Immunoglobulin G Precipitins Staining and Labeling
Chemicals
Antibodies, Antinuclear Immunoglobulin G Precipitins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Beutner E H
Sepulveda M R
Barnett E V
References (22)
22 references, click to expand
  1. The quantitation of nonspecific staining as a guide for improvement of fluorescent antibody conjugates.
    J Immunol. 1967 Jun;98(6):1196-203 PMID: 4165503
  2. FACTORS AFFECTING THE RATE OF REACTION OF FLUORESCEIN ISOTHIOCYANATE WITH SERUM PROTEINS.
    J Immunol. 1964 Aug;93:232-42 PMID: 14202251
  3. Developments in immunofluorescence: the need for standardization.
    J Clin Pathol. 1967 Sep;20(5):720-3 PMID: 4177332
  4. A simple fractionation method for preparation of fluorescein-labeled gamma globulin.
    Proc Soc Exp Biol Med. 1960 Dec;105:655-8 PMID: 13741624
  5. Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.
    Proc Soc Exp Biol Med. 1958 Aug-Sep;98(4):898-900 PMID: 13591380
  6. Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence.
    Immunology. 1967 Mar;12(3):327-37 PMID: 4164034
  7. Isothiocyanate compounds as fluorescent labeling agents for immune serum.
    Am J Pathol. 1958 Nov-Dec;34(6):1081-97 PMID: 13583098
  8. Technical factors affecting the preparation of fluorescent antibody reagents.
    J Immunol. 1961 Jul;87:72-9 PMID: 13751871
  9. Studies on fluorescent antibody staining. I. Non-specific fluorescence with fluorescein-coupled sheep anti-rabbit globulins.
    J Exp Med. 1961 Jul 1;114:89-110 PMID: 13706641
  10. AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS.
    JAMA. 1965 May 24;192:682-8 PMID: 14280515
  11. Factors affecting the degree of nonspecific staining given by fluorescein isothiocyanate labelled globulins.
    J Immunol. 1967 Jun;98(6):1204-12 PMID: 4165230
  12. The chromatographic purification of fluorescein-antibody.
    J Histochem Cytochem. 1961 Sep;9:484-6 PMID: 13882753
  13. Studies on autoantibodies in myasthenia gravis.
    JAMA. 1962 Oct 6;182:46-58 PMID: 13868721
  14. A simple method for determining the labeling efficiency of fluorescein isothiocyanate products.
    Anal Biochem. 1966 Mar;14(3):421-8 PMID: 5944945
  15. A provisional specification for fluorescein-labelled antibody against human globulin (IgG).
    Mon Bull Minist Health Public Health Lab Serv. 1967 Sep;26:179-81 PMID: 4866889
  16. The staining properties of human serum proteins conjugated with purified fluorescein isothiocyanate.
    J Immunol. 1962 Jul;89:124-31 PMID: 13895520
  17. [Immunoelectrophoretic method for the analysis of mixtures of antigenic substances].
    Biochim Biophys Acta. 1955 May;17(1):67-74 PMID: 13239629
  18. Studies on fluorescent antibody staining II. Inhibition by sub- optimally conjugated antibody globulins.
    Proc Soc Exp Biol Med. 1962 Nov;111:416-21 PMID: 13948804
  19. A new fluorescent antibody method: mixed antiglobulin immunofluorescence or labelled antigen indirect immunofluorescence staining.
    Nature. 1965 Oct 23;208(5008):353-5 PMID: 5328384
  20. Staining of complement and modification of fluorescent antibody procedures.
    J Immunol. 1958 Feb;80(2):122-31 PMID: 13514081
  21. Clinical significance of autoantibodies in pemphigus.
    Arch Dermatol. 1966 May;93(5):570-6 PMID: 4161271
  22. PREPARATION OF FLUORESCEIN ISOTHIOCYANATE-LABELED GAMMA-GLOBULIN BY DIALYSIS, GEL FILTRATION, AND IONEXCHANGE CHROMATOGRAPHY IN COMBINATION.
    J Bacteriol. 1965 Mar;89:734-9 PMID: 14273654
Article Info
Journal
Bulletin of the World Health Organization
Abbr.
Bull World Health Organ
ISSN
0042-9686
Published
1968-00-00
Pages
587-606
Language
English
Region
Switzerland
NLM ID
7507052
PMCID
PMC2554396
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]